In our new Antibiotics Deconstructed column, authors discuss the recently approved intravenous fosfomycin (Contepo), with an overview of the therapeutic including its mechanism of action, data, availability, and prospective costs.
#IDsky #Medsky
Antibiotics Deconstructed: IV Fosfomycin | Contagion Live
The FDA recently approved intravenous fosfomycin (Contepo), which is a new option for adults with complicated urinary tract infections, including those caused by resistant Gram-negative pathogens. Her...
